Hikma Pharmaceuticals Plc (LON:HIK)

Hikma Pharmaceuticals PLC is the United Kingdom-based Company that is engaged in the manufacting and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. The Company operates in three business segments: Branded, Injectables, and Generics. The Company’s branded pharmaceuticals are manufactured at facilities located in Jordan, Algeria, Saudi Arabia, Egypt, Tunisia and Morocco. Its Branded business sells 50 under-licensed products. The Company’s Generics business operates as West-Ward Pharmaceuticals, a domestic marketer and manufacturer of generic pharmaceutical products, selling 50 generic compounds in 122 dosage forms and strengths. Its injectable business markets 171 branded and non-branded injectable products in 302 dosage strengths and forms, including fourteen in-licensed products.

Official website: www.hikma.com